| __timestamp | BioMarin Pharmaceutical Inc. | MannKind Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 302156000 | 79383000 |
| Thursday, January 1, 2015 | 402271000 | 108402000 |
| Friday, January 1, 2016 | 476593000 | 46928000 |
| Sunday, January 1, 2017 | 554336000 | 74959000 |
| Monday, January 1, 2018 | 604353000 | 79716000 |
| Tuesday, January 1, 2019 | 680924000 | 74669000 |
| Wednesday, January 1, 2020 | 737669000 | 59040000 |
| Friday, January 1, 2021 | 759375000 | 77417000 |
| Saturday, January 1, 2022 | 854009000 | 91473000 |
| Sunday, January 1, 2023 | 937300000 | 94314000 |
| Monday, January 1, 2024 | 1009025000 |
Unlocking the unknown
In the competitive world of biopharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. Over the past decade, BioMarin Pharmaceutical Inc. and MannKind Corporation have demonstrated contrasting approaches to SG&A efficiency.
From 2014 to 2023, BioMarin's SG&A expenses surged by over 200%, reflecting its aggressive expansion strategy. In contrast, MannKind's expenses grew by a modest 19%, indicating a more conservative approach. By 2023, BioMarin's SG&A expenses were nearly 10 times higher than MannKind's, highlighting its significant investment in administrative and sales functions.
This divergence underscores the strategic choices each company has made in navigating the biopharma landscape. While BioMarin focuses on scaling operations, MannKind opts for a leaner model. Investors and industry analysts should consider these trends when evaluating the long-term sustainability and growth potential of these companies.
Merck & Co., Inc. vs MannKind Corporation: SG&A Expense Trends
BioMarin Pharmaceutical Inc. or Sarepta Therapeutics, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for BioMarin Pharmaceutical Inc. and Walgreens Boots Alliance, Inc.
Operational Costs Compared: SG&A Analysis of BioMarin Pharmaceutical Inc. and Alpine Immune Sciences, Inc.
Breaking Down SG&A Expenses: BioMarin Pharmaceutical Inc. vs TG Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing BioMarin Pharmaceutical Inc. and Rhythm Pharmaceuticals, Inc.
Comparing SG&A Expenses: BioMarin Pharmaceutical Inc. vs Novavax, Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for Catalent, Inc. and MannKind Corporation
Jazz Pharmaceuticals plc or MannKind Corporation: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Amneal Pharmaceuticals, Inc. or MannKind Corporation
HUTCHMED (China) Limited and MannKind Corporation: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Arrowhead Pharmaceuticals, Inc. and MannKind Corporation